{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:03:40Z","timestamp":1790186620096,"version":"4.1.0"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014012","name":"FightMND Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jns.2026.126168","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:46Z","timestamp":1788912046000},"page":"126168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dysfunction of the blood-brain barrier and neurovascular unit in amyotrophic lateral sclerosis \u2013 From advanced human models to treatments"],"prefix":"10.1016","volume":"490","author":[{"given":"Stephani","family":"Viljoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.S.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Peall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-8622","authenticated-orcid":false,"given":"Lotta E.","family":"Oikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.jns.2026.126168_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/21678421.2024.2447919","article-title":"Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS registry (in eng)","volume":"26","author":"Mehta","year":"2025","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0010","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review (in eng)","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"5796","key":"10.1016\/j.jns.2026.126168_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis (in eng)","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2026.126168_bb0035","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/bs.irn.2017.04.009","article-title":"Chapter fifty-one - nonmotor symptoms in amyotrophic lateral sclerosis: a systematic review","volume":"134","author":"Fang","year":"2017"},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/neup.12428","article-title":"Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis\/frontotemporal lobar degeneration","volume":"38","author":"Takeda","year":"2018","journal-title":"Neuropathology"},{"issue":"10360","key":"10.1016\/j.jns.2026.126168_bb0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis (in eng)","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2026.126168_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2019.02.030","article-title":"Genetics of amyotrophic lateral sclerosis: a review (in eng)","volume":"399","author":"Mathis","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126168_bb0060","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: where are we now? (in eng)","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jns.2026.126168_bb0065","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/B978-0-12-802973-2.00013-6","article-title":"Chapter 13 - the epidemiology of amyotrophic lateral sclerosis","volume":"138","author":"Talbott","year":"2016"},{"key":"10.1016\/j.jns.2026.126168_bb0070","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: current insights (in eng)","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-023-00377-7","article-title":"Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges","volume":"12","author":"Zhu","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0080","doi-asserted-by":"crossref","first-page":"630.e3","DOI":"10.1016\/j.neurobiolaging.2011.10.029","article-title":"UNC13A is a modifier of survival in amyotrophic lateral sclerosis","volume":"33","author":"Diekstra","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/jnnp-2022-330851","article-title":"Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients (in eng)","volume":"94","author":"Nakamura","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0090","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng.442","article-title":"Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis","volume":"41","author":"van Es","year":"2009","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.jns.2026.126168_bb0095","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1093\/brain\/awad120","article-title":"Genetic variability in sporadic amyotrophic lateral sclerosis","volume":"146","author":"Van Daele","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-017-0087-3","article-title":"Environmental insults: critical triggers for amyotrophic lateral sclerosis","volume":"6","author":"Yu","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jns.2026.126168_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.851563","article-title":"Breached barriers: a scoping review of blood-central nervous system barrier pathology in amyotrophic lateral sclerosis (in eng)","volume":"16","author":"Mirian","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0271678X231153281","article-title":"Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: proposed mechanisms and clinical implications (in eng)","volume":"43","author":"Steinruecke","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity (in eng)","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jns.2026.126168_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction (in English)","volume":"15","author":"Takata","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases (in eng)","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jns.2026.126168_bb0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnins.2020.00334","article-title":"Neurovascular unit dysfunction and neurodegenerative disorders (in eng)","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166967","article-title":"Blood-brain barrier transporters: an overview of function, dysfunction in Alzheimer\u2019s disease and strategies for treatment (in eng)","volume":"1870","author":"Chaves","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013145","article-title":"Pericytes: the forgotten controllers of a functional blood\u2013brain barrier","volume":"21","author":"Roedel","year":"2025","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.jns.2026.126168_bb0145","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/glia.20990","article-title":"The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction (in eng)","volume":"58","author":"Mathiisen","year":"2010","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/cells13020150","article-title":"Involvement of astrocytes in the formation, maintenance, and function of the blood\u2013brain barrier","volume":"13","author":"Schiera","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jns.2026.126168_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.732820","article-title":"The \u201cneuro-glial-vascular\u201d unit: the role of glia in neurovascular unit formation and dysfunction (in english)","volume":"9","author":"Kugler","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113970","article-title":"Long-range inhibitory neurons mediate cortical neurovascular coupling (in eng)","volume":"43","author":"Ruff","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jns.2026.126168_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2018.07.016","article-title":"Role of oligodendrocyte-neurovascular unit in white matter repair","volume":"684","author":"Hamanaka","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2026.126168_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106200","article-title":"New insights into the roles of oligodendrocytes regulation in ischemic stroke recovery","volume":"184","author":"Huang","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2026.126168_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.706025","article-title":"Emerging roles of microglia in neuro-vascular unit: implications of microglia-neurons interactions (in english)","volume":"15","author":"Ding","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jns.2026.126168_bb0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS (in eng)","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2026.126168_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients (in eng)","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2026.126168_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00021","article-title":"Blood-CNS barrier impairment in ALS patients versus an animal model (in eng)","volume":"8","author":"Garbuzova-Davis","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration (in eng)","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0200","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jnr.22594","article-title":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"89","author":"Miyazaki","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2026.126168_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114084","article-title":"Neurovascular unit pathology is observed very early in disease progression in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis (in eng)","volume":"353","author":"Yoshikawa","year":"2022","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34412-4","article-title":"Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0215","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.18632\/oncotarget.24360","article-title":"Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier (in eng)","volume":"9","author":"Eve","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jns.2026.126168_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2537698","article-title":"Pathomechanisms of blood-brain barrier disruption in ALS (in eng)","volume":"2019","author":"Kakaroubas","year":"2019","journal-title":"Neurosci. J."},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0225","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s13311-018-0624-5","article-title":"Impact of neurodegenerative diseases on drug binding to brain tissues: from animal models to human samples (in eng)","volume":"15","author":"Ugarte","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0230","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.celrep.2019.09.066","article-title":"Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia","volume":"29","author":"Tam","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jns.2026.126168_bb0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2021.11.031","article-title":"Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis","volume":"178","author":"Xiong","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0240","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study (in eng)","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.126168_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.552295","article-title":"Plasma inflammatory cytokines are elevated in ALS (in eng)","volume":"11","author":"Tortelli","year":"2020","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-018-1933-9","article-title":"Inflammation in ALS\/FTD pathogenesis","volume":"137","author":"McCauley","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-017-0896-4","article-title":"Evidence for an early innate immune response in the motor cortex of ALS (in eng)","volume":"14","author":"Jara","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.jns.2026.126168_bb0260","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1523\/JNEUROSCI.4184-10.2011","article-title":"Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G93A transgenic ALS mice (in eng)","volume":"31","author":"Ozdinler","year":"2011","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0265","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/jnr.22424","article-title":"Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis","volume":"88","author":"Sanagi","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0270","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12974-025-03468-6","article-title":"NLRP3 activation induces BBB disruption and neutrophil infiltration via CXCR2 signaling in the mouse brain","volume":"22","author":"Lee","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0275","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/jcbfm.2014.239","article-title":"Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia (in eng)","volume":"35","author":"McKittrick","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0280","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BST20220830","article-title":"The role of the blood-brain barrier during neurological disease and infection (in eng)","volume":"51","author":"Patabendige","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"16","key":"10.1016\/j.jns.2026.126168_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads0505","article-title":"Amyotrophic lateral sclerosis and frontotemporal dementia mutation reduces endothelial TDP-43 and causes blood-brain barrier defects (in eng)","volume":"11","author":"Cheemala","year":"2025","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0290","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41593-025-01914-5","article-title":"Endothelial TDP-43 depletion disrupts core blood\u2013brain barrier pathways in neurodegeneration","volume":"28","author":"Omar","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0295","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"issue":"46","key":"10.1016\/j.jns.2026.126168_bb0300","doi-asserted-by":"crossref","first-page":"29101","DOI":"10.1073\/pnas.2007806117","article-title":"Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction","volume":"117","author":"Peng","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0305","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/cells11071186","article-title":"Neurotoxic astrocytes directly converted from sporadic and familial ALS patient fibroblasts reveal signature diversities and miR-146a theragnostic potential in specific subtypes","volume":"11","author":"Gomes","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS (in eng)","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0315","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40035-022-00332-y","article-title":"Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity","volume":"11","author":"Ng","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0320","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/s41467-023-41603-0","article-title":"C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9","volume":"14","author":"Vahsen","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/cjn.2016.284","article-title":"Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study","volume":"44","author":"Blasco","year":"2017","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0330","article-title":"Aberrations in oxidative stress markers in amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0335","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.410420416","article-title":"Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis","volume":"42","author":"Beal","year":"1997","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0340","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0345","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ana.410380424","article-title":"Oxidative damage to protein in sporadic motor neuron disease spinal cord","volume":"38","author":"Shaw","year":"1995","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0350","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41374-019-0233-x","article-title":"Association between TDP-43 and mitochondria in inclusion body myositis (in eng)","volume":"99","author":"Huntley","year":"2019","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0355","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","article-title":"Poly(GR) in C9ORF72-related ALS\/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons","volume":"92","author":"Lopez-Gonzalez","year":"2016","journal-title":"Neuron"},{"issue":"19","key":"10.1016\/j.jns.2026.126168_bb0360","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1093\/hmg\/ddt249","article-title":"Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1","volume":"22","author":"Pickles","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","article-title":"SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity","volume":"12","author":"Berdy\u0144ski","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00894-022-05072-4","article-title":"Modeling of mutant superoxide dismutase 1 octamers with cross-linked disulfide bonds (in eng)","volume":"28","author":"Zhang","year":"2022","journal-title":"J. Mol. Model."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0375","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bph.70147","article-title":"Increased ATP production and P-glycoprotein activity underlie the marked changes in blood\u2013brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis","volume":"183","author":"Pan","year":"2026","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33608-y","article-title":"Cortical glia in SOD1(G93A) mice are subtly affected by ALS-like pathology","volume":"13","author":"Filipi","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0385","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/brain\/awaf360","article-title":"MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis","volume":"149","author":"Fioretti","year":"2026","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.jns.2026.126168_bb0390","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/jnr.22139","article-title":"Oxidative stress disrupts oligodendrocyte maturation (in eng)","volume":"87","author":"French","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0395","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis (in eng)","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0400","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13258-014-0188-7","article-title":"Animal models of amyotrophic lateral sclerosis and Huntington\u2019s disease","volume":"36","author":"Islam","year":"2014","journal-title":"Genes Genomics"},{"key":"10.1016\/j.jns.2026.126168_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? (in english)","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2026.126168_bb0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2016.12.049","article-title":"Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model","volume":"639","author":"Chan","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0415","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/jcbfm.2015.57","article-title":"Expression of the ALS-causing variant hSOD1G93A leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood\u2013spinal cord barrier model","volume":"35","author":"Meister","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122803","article-title":"Altered blood\u2013brain barrier dynamics in the C9orf72 hexanucleotide repeat expansion mouse model of amyotrophic lateral sclerosis","volume":"14","author":"Pan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jns.2026.126168_bb0425","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2017.03.034","article-title":"In vivo EPR pharmacokinetic evaluation of the redox status and the blood brain barrier permeability in the SOD1G93A ALS rat model","volume":"108","author":"Stamenkovi\u0107","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0430","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01952-9","article-title":"TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model (in eng)","volume":"17","author":"Zamudio","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0435","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41598-017-00993-0","article-title":"Endothelial and astrocytic support by human bone marrow stem cell grafts into symptomatic ALS mice towards blood-spinal cord barrier repair","volume":"7","author":"Garbuzova-Davis","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0440","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-023-00619-2","article-title":"Opinion: more mouse models and more translation needed for ALS","volume":"18","author":"Fisher","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0445","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","article-title":"Uniquely hominid features of adult human astrocytes","volume":"29","author":"Oberheim","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0450","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/dmd.108.024745","article-title":"Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport","volume":"37","author":"Syv\u00e4nen","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0455","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood\u2013brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12868-018-0416-1","article-title":"Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology","volume":"19","author":"Pallebage-Gamarallage","year":"2018","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1750-3639.2003.tb00002.x","article-title":"Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000","volume":"13","author":"Piao","year":"2003","journal-title":"Brain Pathol."},{"issue":"18","key":"10.1016\/j.jns.2026.126168_bb0470","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/WNL.0b013e3181a41228","article-title":"Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS (in eng)","volume":"72","author":"Henkel","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0475","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnen\/nlz142","article-title":"Expression and cellular distribution of P-glycoprotein and breast cancer resistance protein in amyotrophic lateral sclerosis patients","volume":"79","author":"van Vliet","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0480","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood\u2013spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0485","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jnen\/nlaa162","article-title":"TDP-43 vasculopathy in the spinal cord in sporadic amyotrophic lateral sclerosis (sALS) and frontal cortex in sALS\/FTLD-TDP (in eng)","volume":"80","author":"Ferrer","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039216","article-title":"Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis","volume":"7","author":"Brettschneider","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0495","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/14737175.2018.1463160","article-title":"Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses","volume":"18","author":"Agosta","year":"2018","journal-title":"Expert. Rev. Neurother."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052941","article-title":"Molecular imaging of microglial activation in amyotrophic lateral sclerosis","volume":"7","author":"Corcia","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0505","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"20","key":"10.1016\/j.jns.2026.126168_bb0510","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1212\/WNL.0000000000001588","article-title":"Increased oxidative stress is related to disease severity in the ALS motor cortex: a PET study (in eng)","volume":"84","author":"Ikawa","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0515","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16540","article-title":"Brain neurovascular coupling in amyotrophic lateral sclerosis: correlations with disease progression and cognitive impairment (in eng)","volume":"32","author":"Trojsi","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0520","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s10072-021-05731-z","article-title":"Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia (in eng)","volume":"43","author":"Li","year":"2022","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0525","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10072-020-04292-x","article-title":"Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients","volume":"41","author":"Wu","year":"2020","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0530","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40478-021-01244-0","article-title":"Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS (in eng)","volume":"9","author":"Waters","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics (in eng)","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0540","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis (in eng)","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0545","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41598-025-30022-4","article-title":"Correlation analysis of serum neurofilament light chain and glial fibrillary acidic protein levels with amyotrophic lateral sclerosis","volume":"16","author":"Ji","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0550","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.62347\/MBFD3367","article-title":"Plasma glial fibrillary acidic protein as a biomarker of blood-brain barrier integrity in patients with occult cerebral small vessel disease (in eng)","volume":"17","author":"Ma","year":"2025","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0555","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-019-0534-8","article-title":"CSF evidence of pericyte damage in Alzheimer\u2019s disease is associated with markers of blood-brain barrier dysfunction and disease pathology","volume":"11","author":"Miners","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.jns.2026.126168_bb0560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2015.09.025","article-title":"Shedding of soluble platelet-derived growth factor receptor-\u03b2 from human brain pericytes","volume":"607","author":"Sagare","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0565","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s43587-026-01117-y","article-title":"Brain endothelial cell-derived extracellular vesicles (c-BEEVs) as a promising biomarker for brain vascular pathology and cognitive decline","volume":"6","author":"You","year":"2026","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0570","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13195-024-01529-1","article-title":"Assessing blood-brain barrier dysfunction and its association with Alzheimer's pathology, cognitive impairment and neuroinflammation (in eng)","volume":"16","author":"Preis","year":"2024","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.jns.2026.126168_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1065193","article-title":"A human-derived neurovascular unit in vitro model to study the effects of cellular cross-talk and soluble factors on barrier integrity (in eng)","volume":"16","author":"Barberio","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2026.126168_bb0580","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00044-024-03290-4","article-title":"Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening","volume":"33","author":"Lubin","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0585","article-title":"Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction","volume":"10","author":"Nzou","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.126168_bb0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-0716-2289-6_9","article-title":"A novel dynamic human in vitro model for studying the blood-brain barrier (in eng)","volume":"2492","author":"Miranda-Azpiazu","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jns.2026.126168_bb0595","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fncel.2019.00230","article-title":"A novel Transwell blood brain barrier model using primary human cells (in eng)","volume":"13","author":"Stone","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb0600","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/jnc.13923","article-title":"An isogenic blood\u2013brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells","volume":"140","author":"Canfield","year":"2017","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0605","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1038\/srep04160","article-title":"A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources","volume":"4","author":"Lippmann","year":"2014","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb0610","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/hmg\/ddad209","article-title":"ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation (in eng)","volume":"33","author":"Allison","year":"2024","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb0615","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","article-title":"Reconstruction of the human blood\u2013brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes","volume":"26","author":"Blanchard","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0620","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13287-024-03671-x","article-title":"Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility (in eng)","volume":"15","author":"King","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0625","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12987-024-00565-1","article-title":"A patient-derived amyotrophic lateral sclerosis blood-brain barrier model for focused ultrasound-mediated anti-TDP-43 antibody delivery (in eng)","volume":"21","author":"Wasielewska","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"16","key":"10.1016\/j.jns.2026.126168_bb0630","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.7150\/thno.72685","article-title":"A sporadic Alzheimer\u2019s blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-tau antibodies (in eng)","volume":"12","author":"Wasielewska","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jns.2026.126168_bb0635","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ebiom.2019.11.026","article-title":"Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity (in eng)","volume":"50","author":"Birger","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0640","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11481-024-10127-9","article-title":"Differential cytokine responses of APOE3 and APOE4 blood-brain barrier cell types to SARS-CoV-2 spike proteins (in eng)","volume":"19","author":"Chaves","year":"2024","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.009","article-title":"Alzheimer\u2019s disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound (in eng)","volume":"21","author":"Chaves","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0650","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease (in eng)","volume":"12","author":"di Domenico","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0655","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.stemcr.2020.03.011","article-title":"Altered brain endothelial cell phenotype from a familial Alzheimer mutation and its potential implications for amyloid clearance and drug delivery (in eng)","volume":"14","author":"Oikari","year":"2020","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0660","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12987-019-0139-4","article-title":"The role of mutations associated with familial neurodegenerative disorders on blood\u2013brain barrier function in an iPSC model","volume":"16","author":"Katt","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jns.2026.126168_bb0665","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mcn.2013.07.007","article-title":"A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells (in eng)","volume":"56","author":"Burkhardt","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0670","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/s41591-018-0140-5","article-title":"Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent (in eng)","volume":"24","author":"Fujimori","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52213-6","article-title":"Proof-of-concept study of drug brain permeability between in vivo human brain and an in vitro iPSCs-human blood-brain barrier model","volume":"9","author":"Roux","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jns.2026.126168_bb0680","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016950118","article-title":"Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate","volume":"118","author":"Lu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0685","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.stemcr.2019.01.009","article-title":"iPSC-derived brain endothelium exhibits stable, long-term barrier function in perfused hydrogel scaffolds","volume":"12","author":"Faley","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0690","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/ATVBAHA.125.323397","article-title":"Generation of hiPSC-derived brain microvascular endothelial cells using directed differentiation and transcriptional reprogramming (in eng)","volume":"46","author":"Cui","year":"2026","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0695","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.jns.2026.126168_bb0700","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nn.4345","article-title":"ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks","volume":"19","author":"Ho","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0705","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12862","article-title":"Harnessing cellular aging in human stem cell models of amyotrophic lateral sclerosis (in eng)","volume":"18","author":"Ziff","year":"2019","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0710","doi-asserted-by":"crossref","first-page":"114","DOI":"10.31083\/j.fbl2903114","article-title":"The role of human pluripotent stem cells in amyotrophic lateral sclerosis: from biological mechanism to practical implications (in eng)","volume":"29","author":"Ceccarelli","year":"2024","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0715","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cels.2020.10.010","article-title":"Cross-comparison of human iPSC motor neuron models of familial and sporadic ALS reveals early and convergent transcriptomic disease signatures","volume":"12","author":"Ho","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.jns.2026.126168_bb0720","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fnmol.2017.00359","article-title":"Direct reprogramming rather than iPSC-based reprogramming maintains aging hallmarks in human motor neurons (in eng)","volume":"10","author":"Tang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2026.126168_bb0725","doi-asserted-by":"crossref","DOI":"10.1038\/srep26181","article-title":"Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture (in eng)","volume":"6","author":"Odawara","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.126168_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120554","article-title":"Effect of cellular and ECM aging on human iPSC-derived cardiomyocyte performance, maturity and senescence (in eng)","volume":"268","author":"Ozcebe","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0735","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1038\/s41467-024-47758-8","article-title":"Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls","volume":"15","author":"Tsitkov","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2026.126168_bb0740","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease (in eng)","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb0745","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.stem.2016.11.005","article-title":"Analysis of transcriptional variability in a large human iPSC library reveals genetic and non-genetic determinants of heterogeneity","volume":"20","author":"Carcamo-Orive","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104289","article-title":"Multi-omics approach reveals posttranscriptionally regulated genes are essential for human pluripotent stem cells","volume":"25","author":"Iwasaki","year":"2022","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0755","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.stem.2014.07.003","article-title":"The developmental potential of iPSCs is greatly influenced by reprogramming factor selection (in eng)","volume":"15","author":"Buganim","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0760","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23378-0","article-title":"Examining iPSC derived motor neuron variability and genome stability monitoring as a solution","volume":"15","author":"Gaffey","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.126168_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.623950","article-title":"In vitro models of the blood\u2013brain barrier: tools in translational medicine (in English)","volume":"2","author":"Williams-Medina","year":"2021","journal-title":"Front. Med. Technol."},{"issue":"8","key":"10.1016\/j.jns.2026.126168_bb0770","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells (in eng)","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0775","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12987-024-00580-2","article-title":"iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta (in eng)","volume":"21","author":"Ding","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0780","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","article-title":"Huntington\u2019s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits (in eng)","volume":"19","author":"Lim","year":"2017","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0785","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/brain\/awac019","article-title":"Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis (in eng)","volume":"145","author":"Nishihara","year":"2022","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb0790","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/j.2040-4603.2019.tb00076.x","article-title":"Studying human neurological disorders using induced pluripotent stem cells: from 2D monolayer to 3D organoid and blood brain barrier models (in eng)","volume":"9","author":"Logan","year":"2019","journal-title":"Compr. Physiol."},{"issue":"11\u201312","key":"10.1016\/j.jns.2026.126168_bb0795","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/ten.tea.2016.0103","article-title":"Three-dimensional environment sustains morphological heterogeneity and promotes phenotypic progression during astrocyte development (in eng)","volume":"22","author":"Balasubramanian","year":"2016","journal-title":"Tissue Eng. Part A"},{"issue":"1\u20132","key":"10.1016\/j.jns.2026.126168_bb0800","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/ten.tea.2011.0221","article-title":"Substrate three-dimensionality induces elemental morphological transformation of sensory neurons on a physiologic timescale (in eng)","volume":"18","author":"Ribeiro","year":"2012","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.jns.2026.126168_bb0805","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.scr.2017.10.010","article-title":"Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells","volume":"25","author":"Chandrasekaran","year":"2017","journal-title":"Stem Cell Res."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0810","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-024-03037-3","article-title":"Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u2019s disease (in eng)","volume":"21","author":"Cun\u00ed-L\u00f3pez","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0815","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12987-022-00327-x","article-title":"Effects of acute and chronic oxidative stress on the blood-brain barrier in 2D and 3D in vitro models (in eng)","volume":"19","author":"Chung","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jns.2026.126168_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123784","article-title":"Microfluidic devices for the detection of disease-specific proteins and other macromolecules, disease modelling and drug development: a review","volume":"235","author":"Amir","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0825","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1007\/s12035-019-01653-2","article-title":"Microfluidic brain-on-a-chip: perspectives for mimicking neural system disorders (in eng)","volume":"56","author":"Mofazzal Jahromi","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb0830","doi-asserted-by":"crossref","DOI":"10.1063\/1.4935594","article-title":"An optically transparent membrane supports shear stress studies in a three-dimensional microfluidic neurovascular unit model (in eng)","volume":"9","author":"Sellgren","year":"2015","journal-title":"Biomicrofluidics"},{"issue":"11","key":"10.1016\/j.jns.2026.126168_bb0835","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205752","article-title":"3D in vitro blood-brain-barrier model for investigating barrier insults","volume":"10","author":"Wei","year":"2023","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat5847","article-title":"Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons (in eng)","volume":"4","author":"Osaki","year":"2018","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0845","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1177\/0271678X16672482","article-title":"Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium (in eng)","volume":"37","author":"Garcia-Polite","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0850","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease (in eng)","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0855","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40486-024-00219-9","article-title":"A four-channel microfluidic model of the blood\u2013brain and blood\u2013cerebrospinal fluid barriers: fluid dynamics analysis","volume":"12","author":"Libet","year":"2024","journal-title":"Micro Nano Syst. Lett."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0860","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41596-021-00635-w","article-title":"Engineered human blood\u2013brain barrier microfluidic model for vascular permeability analyses","volume":"17","author":"Hajal","year":"2022","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.jns.2026.126168_bb0865","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.3390\/ijms25126496","article-title":"Modeling of blood\u2013brain barrier (BBB) dysfunction and immune cell migration using human BBB-on-a-chip for drug discovery research","volume":"25","author":"Ohbuchi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0870","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12015-023-10645-8","volume":"20","author":"Saglam-Metiner","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"issue":"9","key":"10.1016\/j.jns.2026.126168_bb0875","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nbt.4226","article-title":"A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells","volume":"36","author":"Maoz","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.jns.2026.126168_bb0880","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/brainsci12101293","article-title":"A microfluidic in vitro three-dimensional dynamic model of the blood\u2013brain barrier to study the transmigration of immune cells","volume":"12","author":"Meena","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.jns.2026.126168_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122864","article-title":"Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction (in eng)","volume":"314","author":"Pavlou","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0890","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39038-8","article-title":"The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease","volume":"14","author":"de Rus Jacquet","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0895","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/s41467-021-26066-5","article-title":"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption","volume":"12","author":"Pediaditakis","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150360","article-title":"Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip","volume":"11","author":"Herland","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0905","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81335-z","article-title":"A directional 3D neurite outgrowth model for studying motor axon biology and disease","volume":"11","author":"Spijkers","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0910","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.stem.2025.05.015","article-title":"An organ-chip model of sporadic ALS using iPSC-derived spinal cord motor neurons and an integrated blood-brain-like barrier (in eng)","volume":"32","author":"Lall","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0915","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15623","article-title":"Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents","volume":"8","author":"Cho","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0920","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1038\/s41598-018-25603-5","article-title":"Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling (in eng)","volume":"8","author":"Nzou","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0925","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s41598-023-50203-3","article-title":"A multicellular brain spheroid model for studying the mechanisms and bioeffects of ultrasound-enhanced drug penetration beyond the blood\u2013brain barrier (in eng)","volume":"14","author":"Paranjape","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jns.2026.126168_bb0930","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4399","article-title":"High throughput blood-brain barrier organoid generation and assessment of receptor-mediated antibody transcytosis (in eng)","volume":"12","author":"Kassianidou","year":"2022","journal-title":"Bio Protoc."},{"issue":"7467","key":"10.1016\/j.jns.2026.126168_bb0935","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly (in eng)","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb0940","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41592-018-0255-0","article-title":"Reliability of human cortical organoid generation","volume":"16","author":"Yoon","year":"2019","journal-title":"Nat. Methods"},{"issue":"11","key":"10.1016\/j.jns.2026.126168_bb0945","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41593-021-00923-4","article-title":"Human ALS\/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology","volume":"24","author":"Szeb\u00e9nyi","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.jns.2026.126168_bb0950","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","article-title":"Engineering of human brain organoids with a functional vascular-like system (in eng)","volume":"16","author":"Cakir","year":"2019","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb0955","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","article-title":"Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids (in eng)","volume":"31","author":"Dao","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jns.2026.126168_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105896","article-title":"Commentary on FDA\u2019s shift from animal testing and implications for drug attrition \u2013 the time to act is now","volume":"162","author":"von Keutz","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jns.2026.126168_bb0965","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.996952","article-title":"A 3D cell culture system for bioengineering human neuromuscular junctions to model ALS (in English)","volume":"11","author":"Massih","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jns.2026.126168_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121525","article-title":"Human iPSC-derived brain endothelial microvessels in a multi-well format enable permeability screens of anti-inflammatory drugs","volume":"286","author":"Fengler","year":"2022","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.jns.2026.126168_bb0975","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1039\/D3FO04760A","article-title":"In vitro study of the blood\u2013brain barrier transport of bioactives from Mediterranean foods","volume":"15","author":"Gallardo-Fernandez","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.jns.2026.126168_bb0980","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jns.2026.126168_bb0985","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/j.toxlet.2025.07.635","article-title":"P22-05 investigation of nanoparticles as drug delivery systems in a cellular blood-brain barrier model: an in vitro study","volume":"411","author":"Daraban","year":"2025","journal-title":"Toxicol. Lett."},{"issue":"Pt A","key":"10.1016\/j.jns.2026.126168_bb0990","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2015.10.047","article-title":"Nanoparticle delivery to the brain-by focused ultrasound and self-assembled nanoparticle-stabilized microbubbles (in eng)","volume":"220","author":"\u00c5slund","year":"2015","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jns.2026.126168_bb0995","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ultrasmedbio.2021.01.014","article-title":"Focused ultrasound and microbubble treatment increases delivery of transferrin receptor-targeting liposomes to the brain (in eng)","volume":"47","author":"Olsman","year":"2021","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jns.2026.126168_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117080","article-title":"Promising breakthroughs in amyotrophic lateral sclerosis treatment through nanotechnology\u2019s unexplored frontier","volume":"282","author":"Sojdeh","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.jns.2026.126168_bb1005","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.nano.2016.06.009","article-title":"Cerium oxide nanoparticles with antioxidant properties ameliorate strength and prolong life in mouse model of amyotrophic lateral sclerosis","volume":"12","author":"DeCoteau","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jns.2026.126168_bb1010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2024.11.074","article-title":"Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy (in eng)","volume":"378","author":"Ediriweera","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb1015","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12426-9","article-title":"First-in-human trial of blood\u2013brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound","volume":"10","author":"Abrahao","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb1020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75253-9","article-title":"Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood\u2013brain barrier opening","volume":"10","author":"Ohta","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.126168_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119622","article-title":"Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases","volume":"201","author":"Jaberi","year":"2026","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.jns.2026.126168_bb1030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis (in eng)","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2026.126168_bb1035","article-title":"A human-based functional NMJ system for personalized ALS modeling and drug testing","volume":"3","author":"Guo","year":"2020","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb1040","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery (in eng)","volume":"30","author":"Morimoto","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb1045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17460441.2025.2474661","article-title":"Drug repurposing in amyotrophic lateral sclerosis (ALS) (in eng)","volume":"20","author":"Carroll","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.jns.2026.126168_bb1050","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf184","article-title":"Drug repurposing candidates for amyotrophic lateral sclerosis using common and rare genetic variants","volume":"7","author":"Gerring","year":"2025","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.jns.2026.126168_bb1055","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.stemcr.2021.03.025","article-title":"Balancing serendipity and reproducibility: pluripotent stem cells as experimental systems for intellectual and developmental disorders (in eng)","volume":"16","author":"Anderson","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.jns.2026.126168_bb1060","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2024.2315702","article-title":"Highly scalable and standardized organ-on-chip platform with TEER for biological barrier modeling (in eng)","volume":"12","author":"Nguyen","year":"2024","journal-title":"Tissue Barriers"},{"issue":"1","key":"10.1016\/j.jns.2026.126168_bb1065","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48864-3","article-title":"Roadblocks confronting widespread dissemination and deployment of organs on chips (in eng)","volume":"15","author":"Alver","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:19:30Z","timestamp":1790183970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26004508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":213,"alternative-id":["S0022510X26004508"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126168","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunction of the blood-brain barrier and neurovascular unit in amyotrophic lateral sclerosis \u2013 From advanced human models to treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126168"}}